PIFELTRO

This brand name is authorized in Austria, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug PIFELTRO contains one active pharmaceutical ingredient (API):

1 Doravirine UNII 913P6LK81M - DORAVIRINE

Doravirine is a pyridinone non-nucleoside reverse transcriptase inhibitor of HIV-1 and inhibits HIV-1 replication by non-competitive inhibition of HIV-1 reverse transcriptase (RT). Doravirine does not inhibit the human cellular DNA polymerases α, β, and mitochondrial DNA polymerase γ. Read about Doravirine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PIFELTRO Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AG06		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AG Non-nucleoside reverse transcriptase inhibitors
Discover more medicines within J05AG06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02481545
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5522-MEE-1020
Country: EE	Ravimiamet	Identifier(s): 1783155, 1783166
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181332001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 537089
Country: FR	Base de données publique des médicaments	Identifier(s): 68914027
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 368789
Country: HK	Department of Health Drug Office	Identifier(s): 66558
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8524
Country: IT	Agenzia del Farmaco	Identifier(s): 047421019, 047421021
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250049F1021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086748, 1086749
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 198676
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100416536
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65374001, W65374002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636091548
Country: US	FDA, National Drug Code	Identifier(s): 0006-3069
Country: ZA	Health Products Regulatory Authority	Identifier(s): 53/20.2.8/0232